What is the difference between imported and generic drugs of Vancevi?

Valcyte, generic name Valganciclovir (Valganciclovir), is an antiviral drug used to treat cytomegalovirus (CMV) infection. There are differences in production background, price, efficacy, safety and market accessibility between imported original drugs and generic drugs. The following is a detailed comparison between the two:

1. Production Background

Imported drug: Developed by Roche Pharmaceuticals, it is the original drug of Vancevir. After a complete research and development process, including laboratory research, clinical trials, approval and certification, etc., it cost a lot of money and lasted more than ten years.

The brand guarantees that its quality and efficacy are recognized globally.

Generic drugs: Generic drugs are drugs produced by other pharmaceutical companies based on the ingredients and formulations of the original drug after the patent period of the original drug has expired. Common origins include major generic drug countries such as Laos. The cost is low, but it needs to pass bioequivalence testing to prove that its efficacy is consistent with that of the original drug.

2. Price Difference

Imported drugs: Domestic prices are higher. For example, 450mg*60 tablets of Vancevir usually cost around more than 10,000 yuan. The high price mainly comes from R&D costs, patent protection, import tariffs and premiums from domestic sales channels. It is not yet included in China’s medical insurance, and patients need to purchase it at their own expense.

Generic drugs: The price advantage is significant, such as the Indian version and the Bangladeshi version of Vancevir, 450mg*60 tablets are sold for about 3,000 to 4,000 yuan. Pharmaceutical companies do not have to bear the cost of research and development, and raw materials and labor costs are low at the production site, making prices more attractive.

3. Efficacy and Safety

Imported drugs: As original drugs, the efficacy and safety data are more complete, and long-term use experience around the world provides strong support for their efficacy. The production process is strict and the quality is highly stable, making it suitable for patients who have high requirements for drug safety.

Generic drugs: Generic drugs need to pass bioequivalence testing to prove that they are not significantly different from the original drugs in drug absorption, metabolism and excretion, so the efficacy is usually the same. There may be differences in the production processes and raw material quality of different generic drug manufacturers. When choosing generic drugs, patients must purchase them through reliable channels to ensure drug quality.

4. Market accessibility

Imported drugs: They are already available in the Chinese market, but due to high prices, many patients cannot afford them in the long term. It has not yet been included in medical insurance, and the financial burden on patients is relatively large.

Generic drugs: more advantageous in terms of price, are widely welcomed by patients with limited financial conditions. Most of the purchases are made through international drug purchasing channels, and attention should be paid to choosing legal and compliant purchasing agencies to ensure reliable sources of drugs.

5. Patient Selection Suggestions

If economic conditions permit or higher drug safety requirements are required, priority may be given to importing the original drug Vancevir.

For patients who require long-term treatment and have limited financial resources, generic drugs are a more cost-effective option, but they must be obtained through formal channels.

There are significant differences in price, production background and market accessibility between Vancevi's imported original drugs and generic drugs, but there is generally no essential difference in efficacy and safety after verification. Patients can reasonably choose suitable drugs under the guidance of doctors based on their own economic conditions and treatment needs.

xa0

References

1.《ValcyteInstructions》 https://www.drugs.com/pro/valganciclovir.html

2.Comparative analysis of generic drugs and original drugs https://www.fda.gov